SCHEMBL29133701

SCHEMBL29133701

CCC1(Nc2c(C#N)cnc3ccc(-c4cncc(C(C)(C)O)c4)cc23)C=CC=CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 3/20 0.38
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ IRAK4 Q9NWZ3 1/20 0.38
▸ EGFR P00533 7/20 0.37
▸ PRKDC P78527 4/20 0.37
▸ CYP11B2 P19099 3/20 0.34
▸ SRC P12931 2/20 0.34
▸ KDR P35968 2/20 0.34
▸ ABL1 P00519 1/20 0.34
▸ FLT1 P17948 1/20 0.34
▸ SYK P43405 1/20 0.34
▸ MELK Q14680 3/20 0.33
▸ TNF P01375 3/20 0.32
▸ CYP11B1 P15538 2/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ CDK1 P06493 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133763 0.88 MELK (0.38) PIK3CAIRAK4EGFRPRKDCSRC
SCHEMBL29133737 0.88 MAP4K4 (0.42) PIK3CAPIK3CGIRAK4EGFRPRKDC
SCHEMBL29133706 0.84 ATM (0.40) PIK3CAEGFRPRKDCSRCKDR
SCHEMBL29133754 0.82 IRAK4 (0.51) PIK3CAPIK3CDPIK3CBMTORPIK3CG
SCHEMBL29133758 0.82 EGFR (0.42) PIK3CAPIK3CDPIK3CBPIK3CGEGFR
SCHEMBL29133729 0.82 EGFR (0.52) PIK3CAIRAK4EGFRPRKDCSRC
SCHEMBL29133697 0.82 MELK (0.49) EGFRPRKDCMELK
SCHEMBL29133713 0.82 EGFR (0.44) PIK3CAPIK3CDPIK3CBMTORPIK3CG
SCHEMBL29133718 0.82 MELK (0.49) EGFRMELK
SCHEMBL29133769 0.81 PIK3CA (0.46) PIK3CAPIK3CDPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback